Rupert Huber is a Professor at the Department of Experimental and Applied Physics, University of Regensburg, where he has held a chair since 2010. His research focuses on ultrafast quantum phenomena, terahertz science, and lightwave electronics, with a strong emphasis on nanoscale imaging and quantum materials. He leads the Huber group, which has launched the ERC project 'Orbital Cinema' and produced numerous high-impact publications in journals like Nature and Nano Letters . Chair for Experimental and Applied Physics, University of Regensburg (2010–present) Emmy Noether Group Leader, University of Konstanz (2007–2010) Alexander von Humboldt Fellow, UC Berkeley/Lawrence Berkeley National Lab (2004–2006) His research explores terahertz spectroscopy , quantum materials , and ultrafast nanoscopy , often combining experimental innovation with theoretical insights. Recent work includes groundbreaking studies on exciton dynamics in van der Waals magnets and subcycle imaging of electron wave motion. The group’s publications frequently appear as coverstories in Nature Photonics and Nano Letters . Huber has received prestigious awards such as the Gottfried Wilhelm Leibniz Prize (2019) , ERC Starting Grant (2012) , and OSA Fellowship (2018) . He has supervised numerous Ph.D. and Master’s students, including recent awardees like Joshua Mornhinweg (faculty dissertation prize, 2024) and Josef Riepl (best tutor award, 2024).
Helmut H. Strey is an Associate Professor in the Department of Biomedical Engineering at Stony Brook University. His research focuses on micro- and nanotechnologies for quantitative biology , including single-cell analysis, cancer metabolism modeling, and functional MRI data analysis. He holds academic appointments since 2008 and has pioneered technologies like tumor-on-a-chip and optical decoders for translation stages. Education: PhD in Biophysics (Technical University München, 1993), postdoctoral training at NIH (1994-1998). Awards include the NSF CAREER Award (2000-2005), Dillon Medal (2003), and Weston Visiting Professorship (2020). Research interests span cell-to-cell variability , Warburg effect in cancer , and Bayesian analysis of time-series data . His lab develops tools for 3D tumor microenvironments, MRI-compatible drug delivery systems, and biomimetic neural circuit models. Teaching includes advanced numerical methods in biomedical engineering, quantitative biology, and biomolecular analysis. Active in open hardware projects, including microfluidics controllers and IoT devices for health monitoring.
Dr. Danial Chitnis is a Chancellor's Fellow and Lecturer in Electronics at the School of Engineering, University of Edinburgh. He holds a DPhil in Engineering Science from the University of Oxford (2013) and has expertise in microelectronics, biomedical engineering, and quantum imaging. His research focuses on SPAD arrays, time-of-flight sensors, and wearable optical systems for biomedical applications. Education: BSc in Electronics Engineering, Chamran University of Ahvaz (2002–2007) MSc in Advanced Microelectronics Systems Engineering, University of Bristol (2007–2008) DPhil in Engineering Science, University of Oxford (2009–2013) Research Interests: Single-Photon Avalanche Diode (SPAD) arrays for optical communications and biomedical imaging Quantum-enhanced imaging via QuantIC Hub Wearable sensors for near-infrared spectroscopy (NIRS) AI-driven automation in test and measurement systems Articles Trends: Recent work emphasizes AI integration in electronics design, photon-counting receivers for 6G networks, and portable biomedical devices. Notable contributions include SYCL-based acceleration of circuit simulations and FPGA-driven time-to-digital converters. Grants & Collaborations: Principal Investigator of multiple grants, including EPSRC-funded projects on AI-enhanced human-machine interfaces and quantum technology applications. Collaborates with UCL, QuantIC, and industry partners like Keysight Technologies. Labs/Teams: Co-investigator at QuantIC, the UK Quantum Technology Hub in Quantum Enhanced Imaging. Leads interdisciplinary research on detector arrays and systems for quantum physics and consumer cameras.
Anne-Sophie Chauvin is a Senior Lecturer and Researcher at École Polytechnique Fédérale de Lausanne (EPFL), School of Basic Sciences, within the Institute of Chemical Sciences and Engineering and the Supramolecular Chemistry Laboratory. She actively engages in supramolecular and inorganic chemistry, focusing on f-element (lanthanides and actinides) coordination polymers and luminescent bioprobes for biological and technological applications, including invisible inks and dye-sensitized solar cells. PhD in Bioinorganic Chemistry from University Paris V-René Descartes (thesis on Nitrile Hydratase mimetics) Postdoctoral work at University of Geneva on chiral alcohol configuration analysis Habilitation à Diriger des Recherches (HDR) from University René Descartes (2006) Her research spans Lanthanide and Actinide Chemistry , Luminescence , Coordination Polymers , Metallacages , and Photovoltaic Materials . Recent publications emphasize catalytic spiro stereocenter formation, actinide coordination polymers, and photoredox-enabled biomolecule functionalization. She has supervised PhD students including Andrei Andreichenko , Julien Andrès , Steve Comby , and Aurélien Willauer . Recognitions include Fellowship of the Royal Society of Chemistry (FRSC) and membership in the Swiss Chemical Society (SCS). Current roles include teaching General and Analytical Chemistry to first-year Pharmacy and Biology students at the University of Lausanne (UNIL), overseeing practical sessions, and serving on the EPFL School of Basic Sciences Faculty Council.
Prof. Dr. Petra Schwille is a Director at the Max Planck Institute of Biochemistry and former C4 Professor of Biophysics at Dresden University of Technology . Her work spans molecular and cellular biophysics, synthetic biology, and single-molecule techniques. Academic disciplines: Natural sciences, biological sciences, physical sciences Key roles: Editorial Board member (Nature Methods, Biophysical Journal), Governing Council of Biophysical Society Research Focus includes membrane biophysics, protein interactions, and microfluidic systems. Her publications emphasize Fluorescence Correlation Spectroscopy (FCS) , receptor-ligand dynamics, and self-organization in bacterial cell division. Developed in vitro models for spatial regulation in cells Explored calmodulin availability and morphogen gradient formation Scientific Recognition includes prestigious awards like the Gottfried Wilhelm Leibniz Prize (2010) and the Biofuture grant (1998) . Max Planck Fellow (2005) Young Investigator Award (2003) Leadership & Service involves roles such as Dean of Studies for Nanobiophysics at TU Dresden and Vice Dean of the Dresden International Graduate School for Biomedicine and Bioengineering (DIGS-BB) . She also contributes to editorial and advisory boards in biophysics and science policy.
Daniel Hyde is an Associate Professor in the Department of Psychology at the University of Illinois Urbana-Champaign, affiliated with the College of Liberal Arts & Sciences and the Neuroscience Program. His research explores the nature and development of abstract conceptual knowledge through behavioral and neural measures. PhD in Psychology from Harvard University Hyde investigates cognitive development from infancy to adulthood, focusing on quantitative reasoning , spatial reasoning , and psychological reasoning using techniques like event-related brain potentials (ERPs) , functional near-infrared spectroscopy (fNIRS) , and behavioral assessments. His recent work examines how symbolic number knowledge builds on non-symbolic foundations and how neural sensitivity to mental states in infancy predicts later theory of mind abilities. Hyde's publications demonstrate a consistent focus on numerical cognition, multisensory integration, and developmental neuroscience. He leads the Brain and Cognitive Development Lab , participates in global initiatives like ManyNumbers and ManyBabies , and collaborates across disciplines to apply developmental insights to education and public health contexts.
Anne Berit C. Samuelsen serves as Associate Professor at the Department of Pharmacy, University of Oslo, where she also holds the position of Head of Education. Her academic foundation includes a Cand.pharm. degree and Dr.scient. doctorate, establishing her expertise in pharmaceutical sciences. Her research centers on polysaccharides from natural sources—particularly higher plants, cereals, and fungi (Basidiomycota)—with specialized focus on β-glucans. Key interests include carbohydrate chemistry, pharmacognosy, and the development of biopolymer-based pharmaceutical applications. Her work bridges fundamental structural characterization with practical drug delivery solutions, notably through liposome coating technologies and immunomodulatory compound development. Recent publications reveal a strong trajectory in fungal polysaccharide research, particularly with Pleurotus eryngii and Albatrellus ovinus species. Her team employs advanced techniques like diffusion-ordered NMR spectroscopy to analyze polysaccharide structures while investigating biological activities related to immune receptor binding (Dectin-1, Toll-like receptors) and therapeutic applications. This work demonstrates consistent output in high-impact journals including Carbohydrate Polymers and ACS Applied Bio Materials . She actively contributes to academic instruction through courses such as FARM1150 (Pharmaceutically Oriented Biochemistry), FARM3100 (Pharmacognosy), and FARM5200 (Use of Biopolymers in Pharmaceuticals). Her leadership extends to the Bioactive Natural Substances and Health Effects (BioNatH) research group and the Glyconor Consortium, where she investigates natural product applications for health improvement.
Prof. Dr. Ioachim Pupeza serves as Group Leader in the Department of Spectroscopy/Imaging at the Leibniz Institute of Photonic Technology (Leibniz-IPHT) in Jena, Germany. His research focuses on advanced optical measurement techniques, particularly in the field of field-resolved spectroscopy and precision optical measurements. Dr. Pupeza's research interests center around optical spectroscopy with a particular emphasis on field-resolved techniques that capture the complete electric field waveform of light-matter interactions. His work spans infrared spectroscopy , molecular fingerprinting , ultrafast laser technology , and precision optical measurements . He has made significant contributions to electro-optic sampling techniques, which enable characterization of electric-field waveforms across the terahertz to visible spectral range. His research also extends to mid-infrared light generation , terahertz spintronic emitters , and cavity-enhanced spectroscopy , with applications ranging from fundamental physics to medical diagnostics. Analysis of Dr. Pupeza's recent publications reveals a strong trend toward increasingly sophisticated field-resolved spectroscopy techniques with applications in both fundamental science and practical diagnostics. His work has evolved from basic measurement techniques to applications in cancer detection through molecular fingerprinting of biofluids. A consistent theme across his publications is the pursuit of higher precision, broader bandwidth, and improved sensitivity in optical measurements, often achieving attosecond-level precision. His research bridges physics, engineering, and medical applications, demonstrating how fundamental optical advances can translate to real-world diagnostic tools. Dr. Pupeza leads the research group "Field-Resolved Optical Precision Measurement Methods" at Leibniz-IPHT, which appears to collaborate extensively with other research institutions and groups. His work involves sophisticated laser systems including high-power Yb:YAG thin-disk oscillators, femtosecond enhancement cavities, and dual-oscillator systems for precision measurements. The group's research has implications for molecular spectroscopy, medical diagnostics, and fundamental studies of light-matter interactions at the most fundamental time scales.
Dr. Jonathan Bones is an Associate Professor in the School of Chemical and Bioprocess Engineering at University College Dublin (UCD) and Principal Investigator of the Characterisation and Comparability Group at NIBRT. His research focuses on analytical methods for biopharmaceuticals, including liquid chromatography-mass spectrometry (LC-MS) for protein characterization, glycomics, and process optimization. He holds a BSc and PhD in Analytical Chemistry from Dublin City University. His work has been recognized through inclusion in the Medicine Maker Power List. He leads a team of 18 researchers, supported by SFI, EI, and industry partnerships. Education: BSc in Analytical Science (Chemistry), Dublin City University PhD in Analytical Chemistry, Dublin City University Research Interests: Development of advanced LC-MS platforms for glycomics, proteomics, and bioprocess analysis. Key areas include: Quantitative proteomics/metabolomics for bioprocess monitoring Liquid phase separations for complex bioanalysis Process analytical technology (PAT) His group collaborates with ThermoFisher Scientific on analytical workflows for biopharmaceutical characterization. Articles Trends: Recent work emphasizes analytical methods for AAV vector characterization, biosimilar comparability via MAM/iMAM, and process clearance of excipients. Over 126 publications highlight his contributions to biopharmaceutical quality control and process understanding. Awards: Medicine Maker Power List (2023): Top 100 influential scientists in biopharmaceutical manufacturing and analysis Advising & Grants: Supervises PhD students in bioprocessing and analytical chemistry Funding from Science Foundation Ireland (SFI), Enterprise Ireland (EI), and EU FP7 Industry collaborations with ThermoFisher Scientific and Bristol Myers Squibb Labs & Teams: Leads the Characterisation and Comparability Lab at NIBRT, focused on cutting-edge analytical tools for bioprocess development and product quality assurance.
James S. Duncan is the Ebenezer K. Hunt Professor of Biomedical Engineering at Yale University, with additional appointments in Electrical & Computer Engineering and Radiology & Biomedical Imaging. His research focuses on biomedical image processing, quantitative image analysis using geometrical models, and applications in cardiac function and neuro-structure analysis. He has pioneered image-guided interventions and developed computational frameworks for medical imaging challenges. He holds a Ph.D. from the University of Southern California. His work integrates AI, deep learning, and statistical decision-making to advance medical imaging technologies. Notable contributions include advancements in 3D image segmentation, deformable models, and MRI-based tumor response assessment. Dr. Duncan has received prestigious awards, including IEEE Fellow (2001) and induction into the American Institute for Medical and Biological Engineering (2000). His recent research spans AI-driven hemodynamics modeling, trustworthy healthcare AI guidelines, and molecular MRI innovations in immunotherapy monitoring. He collaborates across disciplines to address challenges in cardiovascular, neuroimaging, and oncological applications.
Dr. Youngchan Kim is a Lecturer in Quantum Biology at the University of Surrey , serving as Director of the Quantum Biology Doctoral Training Centre (QB-DTC). He is affiliated with multiple departments including the School of Biosciences, Advanced Technology Institute, and Quantum Sciences Group. PhD in Physics (2011), Korea Advanced Institute of Science and Technology MSc in Physics (2008), KAIST BSc in Physics (2006), Chung-Ang University Graduate Certificate in Learning and Teaching (2022), Advance HE His research focuses on quantum phenomena in biological systems at physiological temperatures, particularly using femtosecond optical spectroscopy and genetically engineered fluorescent proteins to explore evolutionary adaptations and develop quantum-bio-inspired technologies like room-temperature single-photon sources. The 15 most recent publications span quantum biology, biophotonics, and optical spectroscopy, with particular emphasis on quantum coherence in biological systems , terahertz birefringence , fluorescent protein dynamics , and biomedical imaging innovations . These works demonstrate his interdisciplinary approach bridging physics, biology, and medical applications. As QB-DTC Director, he leads transdisciplinary initiatives fostering collaboration between quantum physics and biosciences. His technical expertise includes time-correlated single-photon counting , common-path interferometry , and ultrafast fluorescence depolarization techniques.
Ambarish Kulkarni is an Assistant Professor in the Department of Chemical Engineering at the University of California, Davis. His research focuses on multi-scale molecular modeling, data science for materials discovery, catalysis, and separations. He combines quantum chemistry methods (e.g., wave function theory, density functional theory) with classical simulations and machine learning to design novel materials for applications in catalysis, energy storage, and environmental remediation. Specific areas of interest include methane activation, CO 2 capture, and heterogeneous electrocatalysis. His work bridges theory and experiment, collaborating with experimental groups to validate computational findings. Notable projects include: Developing catalysts with atomically dispersed metals for enhanced reactivity Designing zeolite materials for selective chemical transformations Creating machine learning workflows to accelerate material discovery Recent research highlights the role of water in CO 2 adsorption mechanisms, the dynamic behavior of confined nanoparticles, and redox-cycling phenomena in zeolite-embedded catalysts. His computational tools like the Multiscale Atomic Zeolite Simulation Environment (MAZE) enable detailed analysis of complex material behaviors. No scientific awards are explicitly listed in the provided information. His advising activities and grants are not detailed in the current data, but his extensive publication record indicates active research collaboration and funding support.
Erwin Schoof is an Associate Professor at the Department of Biotechnology and Biomedicine , Technical University of Denmark. He leads the Cell Diversity Lab and focuses on advancing proteomics and mass spectrometry technologies. Expertise in single-cell proteomics , stem cell niches , and bioinformatics . Active in myelofibrosis and leukemia research , with applications in UN Sustainable Development Goals . Research Trends from 2025–2024 include: Machine learning-driven peptide sequencing (InstaNovo, InstaNexus). Single-cell resolution tools for mapping hematopoietic stem cells and tumor microenvironments . Biomarker discovery in chronic diseases and respiratory conditions . Supervision : Mentors multiple PhD students on single-cell proteomics , omics data analysis , and biotherapeutic production . Labs & Collaborations : Collaborates with international teams on plasma proteomics , 3D bioengineering , and advanced mass spectrometry workflows .
Prof. Dr. Christian Mayer is a Professor in Physical Chemistry at the Faculty of Chemistry, University of Duisburg-Essen. He serves as Head of the working group focusing on origin of life research, nanocapsules, and NMR spectroscopy techniques. His research group is located at Universitätsstraße 5, D-45141 Essen, Germany, with contact information including phone number +49 201 183-2570. Prof. Mayer's research interests primarily focus on the origin of life in deep tectonic fault zones of the first continental fragments, where he collaborates with Prof. Dr. Ulrich Schreiber from the Faculty of Biology and Prof. Dr. Oliver Schmitz from Applied Analytical Chemistry. His work investigates how vesicle formation occurs in tectonic fault systems through cyclic phase transitions of carbon dioxide, creating ideal conditions for molecular evolution. He specializes in pulsed field gradient NMR (PFG-NMR), high-resolution NMR, and solid-state NMR techniques to characterize nanoscale systems including nanocapsules, vesicles, and microemulsions. His recent publication trends reveal a strong interdisciplinary focus spanning physical chemistry, prebiotic chemistry, and astrobiology. The articles demonstrate increasing integration of computational methods with experimental approaches, particularly in analyzing molecular structures and dynamics. His research has evolved from fundamental studies of nanocapsule systems to broader investigations of protocell formation mechanisms under early Earth conditions, with recent work extending to astrobiological contexts including potential life formation on Titan. Prof. Mayer has established significant collaborations across multiple disciplines, particularly with geologists and biologists, to investigate the physical chemical processes that could have led to the emergence of life. His work bridges fundamental physical chemistry with practical applications in nanomedicine, particularly in developing artificial oxygen carriers based on nanocapsule technology. His laboratory utilizes high-pressure facilities to simulate early Earth crust conditions, with a particular focus on supercritical CO 2 environments. The working group combines experimental approaches with theoretical modeling to understand vesicle formation processes and their implications for the origin of cellular life.
Daniel B. Vigneron, PhD is a Professor at the University of California, San Francisco (UCSF) Department of Radiology and Biomedical Imaging. He serves as Director of the Hyperpolarized MRI Technology Resource Center (HMTRC), Director of Human Imaging Core Services, Director of Advanced Imaging Technologies SRG, and Operations Director of the Surbeck Laboratory for Advanced Imaging. As a core member of the UCB/UCSF Graduate Group in Bioengineering, Vigneron has established himself as a leader in molecular imaging research with over three decades of experience at UCSF. Vigneron's research focuses on developing advanced functional and metabolic MRI techniques, particularly hyperpolarized carbon-13 technology, for studying prostate cancer, brain tumors, and other diseases. His work enables non-invasive imaging of metabolic processes, allowing clinicians to monitor therapy effectiveness and guide treatments. The HMTRC, which he founded in 2011 with NIH funding and recently secured a 5-year renewal for, has supported 20 external projects domestically and 15 internationally, produced 239 publications, and trained 149 researchers. Vigneron's lab develops novel coil and software techniques for high-field MRI, MR spectroscopy, and diffusion imaging at 3T and 7T for studying brain, prostate cancer, and other organs. His recent publications demonstrate a clear trajectory toward clinical translation of hyperpolarized carbon-13 MRI across multiple organ systems. The research spans abdominal imaging with advanced denoising techniques, cardiac metabolism studies, whole-brain coverage applications, and cerebral perfusion analysis. This work represents a significant shift from basic science toward practical clinical applications in oncology, cardiology, and neurology, with particular emphasis on standardization for multi-center studies. Scientific Awards: 2022 Outstanding Faculty Mentoring Award from UCSF Department of Radiology and Biomedical Imaging Vigneron has mentored 149 trainees throughout his career, with several former students now serving as faculty members including Duan Xu, Peder Larson, and Susan Noworolski. As Principal Investigator overseeing eight grants, he has secured significant NIH funding for the HMTRC and other research initiatives. His administrative leadership extends to co-chairing the department's Safety and Compliance Committee, where he has helped establish robust safety protocols for PET-MR programs. Vigneron's mentoring philosophy emphasizes adapting to individual needs at different career stages, moving from instructor to coach to manager to cheerleader as trainees progress. The Vigneron Lab, located in Byers Hall on the UCSF Mission Bay campus, operates within the Surbeck Laboratory for Advanced Imaging. The lab group develops novel acquisition techniques and hardware for multinuclear MR spectroscopy, with particular focus on hyperpolarized carbon-13 metabolic imaging. The HMTRC serves as a hub for team science, bringing together researchers from diverse disciplines to advance metabolic imaging technology and its clinical applications.
